Patents by Inventor Katalin Gerber

Katalin Gerber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aminoquinoline derivatives and their use as adenosine A3 ligands
    Patent number: 8071601
    Abstract: The present invention relates to an adenosine A3 receptor ligand of the general formula (I).
    Type: Grant
    Filed: January 18, 2011
    Date of Patent: December 6, 2011
    Assignee: Sanofi-Aventis
    Inventors: Peter Aranyi, Sandor Batori, Geza Timari, Kinga Boer, Zoltan Kapui, Endre Mikus, Katalin Urban-Szabo, Katalin Gerber, Judit Vargane Szeredi, Michel Finet
  • AMINOQUINOLINE DERIVATIVES AND THEIR USE AS ADENOSINE A3 LIGANDS
    Publication number: 20110112092
    Abstract: The present invention relates to an adenosine A3 receptor ligand of the general formula (I).
    Type: Application
    Filed: January 18, 2011
    Publication date: May 12, 2011
    Applicant: sanofi-aventis
    Inventors: Peter ARANYI, Sandor BATORI, Geza TIMARI, Kinga BOER, Zoltan KAPUI, Endre MIKUS, Katalin URBAN-SZABO, Katalin GERBER, Judit VARGANE SZEREDI, Michel FINET
  • AMINOQUINOLINE DERIVATIVES AND THEIR USE AS ADENOSINE A3 LIGANDS
    Publication number: 20110009626
    Abstract: The present invention relates to an adenosine A3 receptor ligand of the general formula (VI?), (VII?) and (VIII?) and their preparation.
    Type: Application
    Filed: August 11, 2010
    Publication date: January 13, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Peter ARANYI, Sandor BATORI, Geza TIMARI, Kinga BOER, Zoltan KAPUI, Endre MIKUS, Katalin URBAN-SZABO, Katalin GERBER, Judit VARGANE SZEREDI, Michel FINET
  • Aminoquinoline derivatives and their use as adenosine A3 ligands
    Patent number: 7799922
    Abstract: The present invention relates to an adenosine A3 receptor ligand of the general formula (I), within those preferably to the antagonists, including a salt, solvate or isomer (tautomer, desmotrop, and optically active isomer) thereof, to a pharmaceutical composition containing the ligand, to the use of the ligand, to its preparation, and intermediates of the ligand of the general formula (II?), (III?), (IV?), (V?), (VI?), (VII?), (VIII?) and (XIII?) and their preparation.
    Type: Grant
    Filed: June 15, 2009
    Date of Patent: September 21, 2010
    Assignee: sanofi-aventis
    Inventors: Peter Aranyi, Sandor Batori, Geza Timari, Kinga Boer, Zoltan Kapui, Endre Mikus, Katalin Urban-Szabo, Katalin Gerber, Judit Vargane Szeredi, Michel Finet
  • Imidazoquinoline derivatives as adenosine A3 receptor ligands
    Patent number: 7709489
    Abstract: This invention is directed to a compound of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, Z, m, n, o, p and r are as defined herein, its preparation, pharmaceutical composition and use as an adenosine A3 receptor ligand preferably an antagonist.
    Type: Grant
    Filed: June 17, 2008
    Date of Patent: May 4, 2010
    Assignee: sanofi-aventis
    Inventors: Peter Aranyi, Laszlo Balazs, Maria Balogh, Sandor Batori, Lajos T. Nagy, Geza Timari, Kinga Boer, Zoltan Kapui, Endre Mikus, Katalin Gerber, Judit Vargane Szeredi, Katalin Urban-Szabo, Erzsebet Walcz
  • AMINOQUINOLINE DERIVATIVES AND THEIR USE AS ADENOSINE A3 LIGANDS
    Publication number: 20090247745
    Abstract: The present invention relates to an adenosine A3 receptor ligand of the general formula (I), within those preferably to the antagonists, including a salt, solvate or isomer (tautomer, desmotrop, and optically active isomer) thereof, to a pharmaceutical composition containing the ligand, to the use of the ligand, to its preparation, and intermediates of the ligand of the general formula (II?), (III?), (IV?), (V?), (VI?), (VII?), (VIII?) and (XIII?) and their preparation.
    Type: Application
    Filed: June 15, 2009
    Publication date: October 1, 2009
    Applicant: SANOFI-AVENTIS
    Inventors: Peter ARANYI, Sandor BATORI, Geza TIMARI, Kinga BOER, Zoltan KAPUI, Endre MIKUS, Katalin URBAN-SZABO, Katalin GERBER, Judit VARGANE SZEREDI, Michel FINET
  • Aminoquinoline derivatives and their use as adenosine A3 ligands
    Patent number: 7547696
    Abstract: The present invention relates to an adenosine A3 receptor ligand of the general formula (I), within those preferably to the antagonists, including a salt, solvate or isomer (tautomer, desmotrop, and optically active isomer) thereof, to a pharmaceutical composition containing the ligand, to the use of the ligand, to its preparation, and intermediates of the ligand of the general formula (II?), (III?), (IV?), (V?), (VI?), (VII?), (VIII?) and (XIII?) and their preparation.
    Type: Grant
    Filed: January 31, 2006
    Date of Patent: June 16, 2009
    Assignee: sanofi-aventis
    Inventors: Peter Aranyi, Sandor Batori, Geza Timari, Kinga Boer, Zoltan Kapui, Endre Mikus, Katalin Urban-Szabo, Katalin Gerber, Judit Vargane Szeredi, Michel Finet
  • IMIDAZOQUINOLINE DERIVATIVES AS ADENOSINE A3 RECEPTOR LIGANDS
    Publication number: 20080255110
    Abstract: This invention is directed to a compound of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, Z, m, n, o, p and r are as defined herein, its preparation, pharmaceutical composition and use as an adenosine A3 receptor ligand preferably an antagonist.
    Type: Application
    Filed: June 17, 2008
    Publication date: October 16, 2008
    Applicant: SANOFI-AVENTIS
    Inventors: Peter ARANYI, Laszlo BALAZS, Maria BALOGH, Sandor BATORI, Lajos T. NAGY, Geza TIMARI, Kinga BOER, Zoltan KAPUI, Endre MIKUS, Katalin GERBER, Judit VARGANE SZEREDI, Katalin URBAN-SZABO, Erzsebet WALCZ
  • Imidazoquinoline derivatives as adenosine A3 receptor ligands
    Patent number: 7419977
    Abstract: This invention is directed to a compound of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, Z, m, n, o, p and r are as defined herein, its preparation, pharmaceutical composition and use as an adenosine A3 receptor ligand preferably an antagonist.
    Type: Grant
    Filed: May 16, 2005
    Date of Patent: September 2, 2008
    Assignee: Sanofi-Aventis
    Inventors: Peter Aranyi, Laszlo Balazs, Maria Balogh, Sandor Batori, Lajos T. Nagy, Geza Timari, Kinga Boer, Zoltan Kapui, Endre Mikus, Katalin Gerber, Judit Vargane Szeredi, Katalin Urban Szabo, Erzsebet Walcz
  • Imidazoquinoline derivatives and their use as adenosine A3 ligands
    Patent number: 7176213
    Abstract: The present invention relates to adenosine A3 receptor ligands of the general formula (I), within those preferably antagonists, as well as their salts, solvates and isomers, and the pharmaceutical compositions containings them, to the use of the compounds of the general formula (I), as well as their salts, solvates and isomers, to the preparation of the compounds of the general formula (I) and their salts, solvates and isomers, furthermore to the new intermediates of the general formulae (II) and (III) and to the preparation thereof.
    Type: Grant
    Filed: December 17, 2002
    Date of Patent: February 13, 2007
    Assignee: Sanofi-Aventis
    Inventors: Péter Arányi, László Balázs, Mária Balogh, Sándor Bátori, Kinga Boér, Katalin Gerber, Zoltán Kapui, Endre Mikus, Geza Tímári, T. Nagy Lajos, Katalin Urbán-Szabó, Judit Vargáné Szeredi
  • Aminoquinoline derivatives and their use as adenosine A3 ligands
    Publication number: 20060211689
    Abstract: The present invention relates to an adenosine A3 receptor ligand of the general formula (I), within those preferably to the antagonists, including a salt, solvate or isomer (tautomer, desmotrop, and optically active isomer) thereof, to a pharmaceutical composition containing the ligand, to the use of the ligand, to its preparation, and intermediates of the ligand of the general formula (II?), (III?), (IV?), (V?), (VI?), (VII?), (VIII?) and (XIII?) and their preparation.
    Type: Application
    Filed: January 31, 2006
    Publication date: September 21, 2006
    Applicant: sanofi-aventis U.S. LLC
    Inventors: Peter Aranyi, Sandor Batori, Geza Timari, Kinga Boer, Zoltan Kapui, Endre Mikus, Katalin Urban-Szabo, Katalin Gerber, Judit Vargane Szeredi, Michel Finet
  • Imidazoquinoline derivatives as adenosine A3 receptor ligands
    Publication number: 20050234056
    Abstract: This invention is directed to a compound of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, Z, m, n, o, p and r are as defined herein, its preparation, pharmaceutical composition and use as an adenosine A3 receptor ligand preferably an antagonist.
    Type: Application
    Filed: May 16, 2005
    Publication date: October 20, 2005
    Applicant: sanofi-aventis
    Inventors: Peter Aranyi, Laszlo Balazs, Maria Balogh, Sandor Batori, Lajos Nagy, Geza Timari, Kinga Boer, Zoltan Kapui, Endre Mikus, Katalin Gerber, Judit Vargane Szeredi, Katalin Szabo, Erzsebet Walcz
  • Imidazoquinoline derivatives
    Publication number: 20050070566
    Abstract: The present invention relates to adenosine A3 receptor ligands of the general formula (I), within those preferably antagonists, as well as their salts, solvates and isomers, and the pharmaceutical compositions containings them, to the use of the compounds of the general formula (I), as well as their salts, solvates and isomers, to the preparation of the compounds of the general formula (I) and (heir salts, solvates and isomers, furthermore to the new intermediates of the general formulae (II) and (III) and to the preparation thereof.
    Type: Application
    Filed: December 17, 2002
    Publication date: March 31, 2005
    Inventors: Peter Aranyl, Laszlo Balazs, Maria Balogh, Sandor Batori, Kinga Boer, Katalin Gerber, Zoltan Kapui, Endre Mikus, Geza Timari, T. Lajos, Katalin Urban-Szabo, Judit Vargane Szeredi